Cargando…
Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins
SIMPLE SUMMARY: In this study, a multiplexed strategy based on the combination of a nanoparticle-enabled blood test and serum levels of acute-phase proteins proved to be able to distinguish pancreatic cancer patients from healthy controls with a good and sex-dependent prediction ability. This study...
Autores principales: | Caputo, Damiano, Coppola, Alessandro, Quagliarini, Erica, Di Santo, Riccardo, Capriotti, Anna Laura, Cammarata, Roberto, Laganà, Aldo, Papi, Massimiliano, Digiacomo, Luca, Coppola, Roberto, Pozzi, Daniela, Caracciolo, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563576/ https://www.ncbi.nlm.nih.gov/pubmed/36230585 http://dx.doi.org/10.3390/cancers14194658 |
Ejemplares similares
-
Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
por: Digiacomo, Luca, et al.
Publicado: (2023) -
Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
por: Di Santo, Riccardo, et al.
Publicado: (2020) -
Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer
por: Caputo, Damiano, et al.
Publicado: (2020) -
Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles
por: Digiacomo, Luca, et al.
Publicado: (2021) -
Magnetic Levitation of Personalized Nanoparticle–Protein Corona as an Effective Tool for Cancer Detection
por: Quagliarini, Erica, et al.
Publicado: (2022)